# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Keefe, Bruyette & Woods analyst Tommy McJoynt reiterates Root (NASDAQ:ROOT) with a Outperform and lowers the price targe...
UBS analyst Brian Meredith maintains Root (NASDAQ:ROOT) with a Neutral and lowers the price target from $71 to $61.
Root (NASDAQ:ROOT) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(1.93) by 73.06...
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...
GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...